11 Does the percentage of Gleason 4 in targeted prostate biopsies predict the percentage of Gleason 4 at final pathology in prostatectomy specimen? Implications for active surveill... by J. Walz, A. Cavigla, S. Knipper, N. Branger, S. Brunelle, G. Gravis, N. Salem, G. Pignot

Get full text

Permafrost degradation in the Western Russian Arctic by Alexander A Vasiliev, Dmitry S Drozdov, Andrey G Gravis, Galina V Malkova, Kelsey E Nyland, Dmitry A Streletskiy

Get full text

Randomized phase III trial of dose-dense MVAC or GC as perioperative chemotherapy for muscle-invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VE... by C. Pfister, G. Gravis, A. Flechon, M. Soulie, L. Guy, B. Laguerre, N. Mottet, F. Joly, Y. Allory, V. Harter, S. Culine

Get full text

Nephrectomy after complete response to immune checkpoint inhibitors for metastatic Renal Cell Carcinoma (mRCC): A new surgical challenge? by G. Pignot, A. Thiery-Vuillemin, J. Walz, H. Lang, P. Werle, L. Balssa, L. Geoffrois, L. Leblanc, L. Albigès, V. Di Nunno, K. Bensalah, S. Ladoire, G. Gravis, P. Barthélémy

Get full text

Role of prior nephrectomy for synchronous metastatic Renal Cell Carcinoma (mRCC) on efficacy in patients treated with Avelumab + Axitinib (A + Ax) or Sunitinib (S): Results from JA... by M-O. Grimm, M. Oya, T. Choueiri, M. Schmidinger, D.I. Quinn, G. Gravis-Mescam, E. Marseille, A.J.M. Van Den Eertwegh, A. Di Pietro, M. Mariani, J. Wang, D. Thomaidou, L. Albiges

Get full text

Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results by J.M. Piulats, E. Yu, G. Gravis, B. Laguerre, J. Arranz, S. Oudard, P. Fong, M. Kolinsky, M. Augustin, S. Feyerabend, A.. Kam, H. Gurney, A. Tafreshi, M. Retz, W. Berry, N. Mar, H. Wu, C. Schloss, C. Poehlein, J. De Bono

Get full text

KEYNOTE-365 cohort B updated results: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza) pre-treated patients with metastatic castrati... by G. Gravis, M. Kolinsky, L. Mourey, J.M. Piulats, S. Sridhar, E. Romano, W. Berry, H. Gurney, M. Retz, L. Appleman, M. Boegemann, J. De Bono, A. Joshua, U. Emmenegger, H. Conter, B. Laguerre, H. Wu, C. Schloss, C. Poehlein, E.Y. Yu

Get full text

KEYNOTE-365 cohort c updated results: Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients with metastatic Castration-Resistant Prostate Cancer... by S. Feyerabend, W. Berry, P. Fong, J.M. Piulats, L. Appleman, H. Conter, N. Shore, G. Gravis, B. Laguerre, H. Gurney, M. Retz, E. Romano, L. Mourey, J. De Bono, A. Kam, U. Emmenegger, H. Wu, C. Schloss, C. Poehlein, E.Y. Yu

Get full text

Urachal carcinoma: a large retrospective multicentric study from the French Genito-Urinary Tumor Group by M. Guerin, C. Miran, E. Colomba, M. Cabart, T. Herrmann, S. Pericart, D. Maillet, Y. Neuzillet, A. Deleuze, E. Coquan, M. Laramas, C. Thibault, B. Abbar, B. Mesnard, D. Borchiellini, C. Dumont, E. Boughalem, JL. Deville, M. Cancel, C. Saldana, A. Khalil, G. Baciarello, A. Flechon, J. Walz, G. Gravis

Get full text